DOI:
10.1055/s-00034924
Nuklearmedizin - NuclearMedicine
LinksClose Window
References
Schomäcker K, Dietlein M, Schnell R. et al.
Radio-immunotherapy with yttrium-90 ibritumomab tiuxetan.
Clinical considerations, radiopharmacy, radiation protection, perspectives. Nuklearmedizin 2005;
44: 166-177.
Access:
We do not assume any responsibility for the contents of the web pages of other providers.